Active Pharmaceutical Ingredients Market by API Synthesis (Biotech API, Synthetic Chemical API, and HPAPI), by Type of Manufacturing (Contract Manufacturing and In-House API Manufacturing), by Type of API (Synthetic API and Biological API), by Drug type (Into Branded Drugs, Generic Drugs and OTC Drugs), for Cardiology, Oncology, Anti-Inflammatory, Gastrointestinal and Other Application - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Global active pharmaceutical ingredient market to reach USD 213.84 billion in 2021 and is growing at a CAGR of 6.3% during 2016-2021

02-Aug-2016 | Number of pages: 110 | Report Code: ZMR-56 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the active pharmaceutical ingredient market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the active pharmaceutical ingredient along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the active pharmaceutical ingredient market on a global level.

In order to give the users of this report a comprehensive view on the active pharmaceutical ingredient market, we have included a detailed segmentation of active pharmaceutical ingredient. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the active pharmaceutical ingredient market has also been included. The study encompasses a market attractiveness analysis, wherein type segments and application segments are benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view on the active pharmaceutical ingredient market by segmenting the market based on API synthesis, biotech API, synthetic chemical API and HPAPI. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The active pharmaceutical ingredient market’s manufacturing type segment includes contract manufacturing and in-house API manufacturing. The drug type segment includes branded drugs, generic drugs, and OTC drugs. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific and Rest of the world. This segmentation includes demand for active pharmaceutical ingredient based on individual applications in all the regions.

The key players active in this market are Sun Pharmaceuticals Industries Limited, Novartis International AG, BASF SE, Pfizer, Inc., Aurobindo, Albemarle Corporation, and Boehringer Ingelheim among others.

The report segments the global active pharmaceutical ingredient market as

Active Pharmaceutical Ingredient Market: API Synthesis Segment Analysis

  • Biotech API
  • Synthetic Chemical API
  • HPAPI

Active Pharmaceutical Ingredient Market: Type of Manufacturing Segment Analysis

  • Contract Manufacturing
  • In-House API Manufacturing

Active Pharmaceutical Ingredient Market: Type of API Segment Analysis

  • Synthetic API
  • Biological API

Active Pharmaceutical Ingredient Market: Drug Type Segment Analysis

  • Branded Drugs
  • Generic Drugs
  • OTC Drugs

Active Pharmaceutical Ingredient Market: Therapeutic Application Segment Analysis

  • Cardiology
  • Oncology
  • Anti-Inflammatory
  • Gastrointestinal 
  • Other

Related Reports

Thrombus Precursor Protein Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1918 | Report Format:

Global Thrombus Precursor Protein Market: Overview One of the components of the fibrinolytic and coagulation pathways is the thrombus precursor protein (TpP). The thrombus precursor protein acts as a biomarker that specifies the exposure of the people to serious cardiovascular diseases, especial...Read More

Oncology Adjuvants Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1914 | Report Format:

Global Oncology Adjuvants Market: Overview Oncology adjuvant treatment is a treatment for the cancer therapy, wherein which after the primary treatment the cancer treatment is involved. The reoccurrence of the cancer is minimized by the oncology adjuvants treatment. The oncology adjuvant therapy...Read More

Limb Salvage Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1911 | Report Format:

Global Limb Salvage Systems Market: Overview The alternative name for the limb salvage is limb sparing surgery. In the case of the bone tumors, this is the surgical procedure that is mostly preferred so that there are no chances of amputations. In the limb salvage surgery, the functional limb im...Read More

Meningococcal Disease Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1899 | Report Format:

Global Meningococcal Disease Treatment Market: Overview Meningococcal disease is a rigorous infection of meninges; in this disease, the membrane of the brain is affected which causes the brain damage. It is caused by Neisseria meningitides bacteria. This bacterium also causes bloodstream infecti...Read More

Injectable Anti-Wrinkle Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1897 | Report Format:

Global Injectable Anti-Wrinkle Market: Overview In order to reduce the wrinkles and the skin lines, people undergo treatment which is known as injectable antiwrinkle treatment where the drugs are injected into the treatment area. It can also make the skin tight and can fill the sagging skin, fro...Read More

Choose License Type:
Latest Published Reports

View All Published Reports